AACR-NCI-EORTC Poster A044
Precision Medicine Platform to Predict Clinical Responses for Ovarian Cancer

A Precision Medicine Platform To Predict The Clinical Response To Chemo And Immunotherapy For Epithelial Ovarian Cancer
Download poster (Pdf)

Discovery of Precision Oncology Drugs

NTRC provides in vitro drug discovery services focused on Precision Medicine. We help you to find the informed route to the clinic. Information can be found at www.oncolines.com

Predictive Precision Medicine Platform for Ovarian Cancer

The poster presents a biomarker discovery platform using ascites of ovarian cancer patients. The aim is to develop a Precision Medicine Platform to predict the clinical response to chemo- and immunotherapy for epithelial ovarian cancer patients.

NTRC Mechanistic Cell Biology

MECHANISTIC CELL BIOLOGY

Cell biology to determine
mechanism of action
of drug candidates

read more
NTRC ONCOLINES™

ONCOLINES™

Cancer Cell Line
Proliferation Assays
and Bioinformatics

read more
NTRC SYNERGYFINDER™

SYNERGYFINDER™

Combination studies
to identify
novel synergies

read more

Information Needed?

Please contact us for more information

+31 412 700500
Send e-mail